Facebook tracking pixel
S10.AI
ICD-10-CM · H53.8GeneralSystemic

Decreased Visual Acuity

Understanding Decreased Visual Acuity, Low Vision, and Vision Loss: This resource provides information on the diagnosis, clinical documentation, and medical coding of visual impairment for healthcare professionals. Learn about causes, symptoms, and treatment options related to Decreased Visual Acuity. Find essential information for accurate medical coding and improved patient care.

Also known as
Low VisionVisual ImpairmentVision Loss
Definition

Reduced sharpness of vision, affecting near or distant sight.

Clinical signs

Blurry vision, difficulty reading, squinting, eye strain, bumping into objects.

Common settings

Ophthalmology clinic, optometrist office, low vision rehabilitation center.

Related Codes

ICD-10 Code Families

Complete code families applicable to H53.8

H54.0-H54.7
Blindness and low vision
H53.0-H53.8
Visual disturbances
Z71.0-Z71.9
Persons encountering health services
Code Comparison

When to use each related code

DescriptionWhen to use
Reduced sharpness of vision.Use for any reduction in vision not correctable by lenses, impacting daily life. Consider severity.
Blurred vision, near or far.When patient reports blurry vision, specify near, far, or both. Investigate underlying causes.
Complete or partial absence of vision.Document the extent and cause of blindness. Includes legal blindness definitions.
Documentation

Best-practice checklist

  • Document visual acuity measurements for both eyes (e.g., 20/40 OD, 20/60 OS).
  • Specify onset and duration of decreased visual acuity.
  • Describe impact on daily activities (e.g., reading, driving).
  • Document any associated symptoms (e.g., pain, blurred vision).
  • List relevant medical history, including eye conditions and treatments.
Coding & Audit Risks

Common pitfalls to avoid

Laterality Coding

Missing or incorrect laterality (right, left, both) can lead to claim denials and inaccurate data reporting for decreased visual acuity.

Severity Specificity

Lack of documentation specifying mild, moderate, or severe visual impairment may cause coding errors impacting reimbursement and quality metrics.

Underlying Cause

Failure to code the underlying etiology (e.g., macular degeneration, diabetic retinopathy) with decreased visual acuity can affect risk adjustment and statistical analysis.

Mitigation

Best-practice tips

  • 01Annual eye exams, diagnose early (ICD-10 H54.x, Z13.5)
  • 02Optimize lighting, magnification, assistive devices (CPT 92002-92015)
  • 03Medication management, treat underlying conditions (HCC coding)
  • 04Vision rehab, training for daily living skills (SNOMED CT)
  • 05Patient education, resources, support groups for compliance
Clinical Decision Support

Step-by-step checklist

  1. 1

    Confirm acuity test method (Snellen, etc.) and document.

  2. 2

    Assess both distance and near vision. Record each eye.

  3. 3

    Rule out refractive error. Is correction adequate?

  4. 4

    Consider underlying causes (e.g., cataracts, AMD).

  5. 5

    Document impact on daily living and driving safety.

Documentation Template

Ready-to-paste narrative

Patient presents with decreased visual acuity, also documented as low vision, visual impairment, or vision loss.  Onset of  [Specify onset - e.g., gradual, sudden] blurred vision, difficulty seeing at [Specify - e.g., distance, near, night], andor [Specify other symptoms - e.g., eye pain, halos, floaters] was noted [Specify timeframe - e.g., one week ago, three months prior].  Best-corrected visual acuity measured [Specify right eye VA] in the right eye and [Specify left eye VA] in the left eye using [Specify chart - e.g., Snellen chart, ETDRS chart] at [Specify distance - e.g., 20 feet, 1 meter].  Refraction revealed [Specify refractive error if applicable - e.g., myopia, hyperopia, astigmatism].  Ocular examination revealed [Document pertinent findings - e.g., normal anterior segment, clear lens, presence of cataracts, macular degeneration, optic nerve abnormalities].  Assessment suggests possible etiologies including [List differential diagnoses - e.g., refractive error, cataracts, macular degeneration, diabetic retinopathy, glaucoma, optic neuritis].  Plan includes [Outline plan - e.g., further diagnostic testing such as OCT, visual field testing, referral to ophthalmology, low vision rehabilitation, prescription for corrective lenses].  Patient education provided regarding diagnosis, management, and prognosis.  ICD-10 code [Specify appropriate ICD-10 code - e.g., H54.2, H54.1, H54.3] is considered.  Return to clinic scheduled for [Specify timeframe - e.g., 2 weeks, 1 month] for follow-up and reassessment of visual acuity.  Medical decision making complexity is [Specify level - e.g., low, moderate, high] based on patient presentation and diagnostic uncertainty.
FAQs

Common questions and answers

What are the most effective differential diagnosis strategies for sudden decreased visual acuity in adults, considering both common and rare etiologies?+

Sudden decreased visual acuity in adults warrants a prompt and thorough evaluation to identify the underlying cause. Common etiologies to consider include retinal detachment, vitreous hemorrhage, central retinal artery occlusion, acute angle-closure glaucoma, optic neuritis, and ischemic optic neuropathy. Rarer, but crucial to consider, are giant cell arteritis, posterior scleritis, and intracranial masses compressing the optic pathways. Differential diagnosis strategies involve a detailed history focusing on symptom onset, associated symptoms (e.g., pain, floaters, halos), and relevant medical history (e.g., diabetes, hypertension, autoimmune disease). A comprehensive eye exam, including visual acuity assessment, pupillary examination, slit-lamp biomicroscopy, and dilated fundus examination, is paramount. Further investigations like optical coherence tomography (OCT), fluorescein angiography, and neuroimaging may be indicated depending on initial findings. Consider implementing a standardized diagnostic algorithm to ensure all potential causes are systematically evaluated. Learn more about evidence-based diagnostic approaches for sudden vision loss in adults by exploring the latest clinical guidelines.

How can I differentiate between transient visual obscurations and permanent decreased visual acuity when evaluating a patient complaining of vision changes?+

Differentiating between transient visual obscurations (TVOs) and permanent decreased visual acuity hinges on understanding the nature and duration of the vision changes. TVOs are typically brief episodes of vision loss, often described as a graying out, blurring, or curtain coming down over the visual field, which resolve spontaneously within seconds to minutes. They can be associated with conditions like migraine, carotid artery stenosis, or papilledema. Permanent decreased visual acuity, on the other hand, represents a sustained reduction in vision that doesn't improve on its own. Causes include macular degeneration, cataracts, glaucoma, and optic nerve damage. Clinicians should gather a detailed history, including the frequency, duration, and characteristics of the visual disturbances, as well as associated symptoms like headache, neurological deficits, or eye pain. A comprehensive eye examination, including visual field testing, is essential. Further investigations, like carotid Doppler ultrasound or neuroimaging, may be necessary to pinpoint the etiology. Explore how a comprehensive approach, combining thorough history taking and targeted investigations, can help distinguish between TVOs and permanent vision loss to guide appropriate management.

What are the best practices for managing decreased visual acuity related to age-related macular degeneration (AMD) in elderly patients, including emerging therapies and supportive care?+

Managing decreased visual acuity related to age-related macular degeneration (AMD) in elderly patients requires a multi-faceted approach. For dry AMD, lifestyle modifications like smoking cessation, a balanced diet rich in antioxidants, and UV protection are recommended. Regular monitoring of disease progression using Amsler grid and visual acuity testing is crucial. For wet AMD, anti-VEGF injections are the standard of care, aiming to slow or halt disease progression and potentially improve visual acuity. Emerging therapies, such as gene therapy and sustained-release drug delivery systems, hold promise for future treatment options. Supportive care plays a vital role in enhancing patients' quality of life. Low vision rehabilitation services, including assistive devices like magnifiers and specialized lighting, can improve patients' ability to perform daily activities. Consider implementing patient education programs to address patients' concerns and empower them to actively participate in their care. Learn more about the latest advances in AMD management, including emerging therapies and best practices for supportive care, by consulting the latest clinical trials and evidence-based guidelines.

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.